Alphamab Oncology
Biopharmaceutical company focused on antibody and antibody-drug conjugate therapies for cancer.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Breast Cancer
Safety of KN057 Prophylaxis in Patients With Haemophilia A or BPhase 3 · Recruiting · Hemophilia A or B
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of CarePhase 3 · Recruiting · Triple Negative Breast Cancer
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid TumorsPhase 1 · Recruiting · Advanced Malignant Solid Tumor
JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian CancerPhase 3 · Not Yet Recruiting · Ovarian Cancer
To Evaluate the Efficacy and Safety of KN060 in Essential HypertensionPhase 1 · Recruiting · Hypertension
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/alphamab-oncology/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.